Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Reliefacyn
- Development stage
- Unknown
- Lead developer
- Sonoma Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Reliefacyn is a topical hydrogel developed by Sonoma Pharmaceuticals for the management of various skin conditions, including atopic dermatitis (eczema), psoriasis, and rosacea. The product's active ingredient is stabilized hypochlorous acid (HOCl), produced using proprietary Microcyn Technology. Reliefacyn functions as an antimicrobial cleansing agent that reduces the microbial load on the skin and alleviates symptoms such as itching, pain, and inflammation. It is formulated as an alcohol-free, steroid-free, and antibiotic-free hydrogel, and it has received clearances and recognitions from major dermatological organizations, including the National Eczema Association and the National Psoriasis Foundation.
- Brand names
- ReliefacynReliefacyn Advanced
- Other names
- Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel
Beyond the preview
Go deeper on Reliefacyn.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reliefacyn.